Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A clinical prognostic scoring system for Guillain-Barré syndrome.
van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. van Koningsveld R, et al. Among authors: swan av. Lancet Neurol. 2007 Jul;6(7):589-94. doi: 10.1016/S1474-4422(07)70130-8. Lancet Neurol. 2007. PMID: 17537676
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002063. doi: 10.1002/14651858.CD002063.pub5. Cochrane Database Syst Rev. 2012. PMID: 22786476 Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD002063. doi: 10.1002/14651858.CD002063.pub6. Cochrane Database Syst Rev. 2014. PMID: 25238327 Free PMC article. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD002063. doi: 10.1002/14651858.CD002063.pub4. Cochrane Database Syst Rev. 2010. PMID: 20556755 Updated. Review.
Corticosteroids for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001446. doi: 10.1002/14651858.CD001446.pub3. Cochrane Database Syst Rev. 2010. PMID: 20166061 Updated. Review.
Immunotherapy for Guillain-Barré syndrome: a systematic review.
Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Hughes RA, et al. Among authors: swan av. Brain. 2007 Sep;130(Pt 9):2245-57. doi: 10.1093/brain/awm004. Epub 2007 Mar 2. Brain. 2007. PMID: 17337484 Review.
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.
Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Hadden RD, et al. Among authors: swan av. Neurology. 2001 Mar 27;56(6):758-65. doi: 10.1212/wnl.56.6.758. Neurology. 2001. PMID: 11274311 Clinical Trial.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Raphaël JC, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002063. doi: 10.1002/14651858.CD002063.pub3. Cochrane Database Syst Rev. 2006. PMID: 16437439 Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Raphaël JC, Swan AV, Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2004;(1):CD002063. doi: 10.1002/14651858.CD002063.pub2. Cochrane Database Syst Rev. 2004. PMID: 14973982 Updated. Review.
109 results